Bpifrance SA - 27 Mar 2025 Form 3 Insider Report for DBV Technologies S.A. (DBVT)

Role: 10%+ Owner
Signature: /s/ Sophie Paquin, Director of Legal Affairs, Bpifrance Participations S.A.
Issuer symbol: DBVT
Transactions as of: 27 Mar 2025
Net transactions value: $0
Form type: 3
Filing time: 07 Apr 2025, 16:01:09 UTC
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	DBVT	Ordinary Shares						10,672,462	27 Mar 2025	By Bpifrance Participations S.A.	F1
holding	DBVT	Ordinary Shares						226,133	27 Mar 2025	By Innobio FPCI	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	DBVT	Warrants (right to buy)							27 Mar 2025	Ordinary Shares	6,556,781		By Bpifrance Participations S.A.	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Bpifrance Participations S.A. ("Bpifrance Participations") directly owns the reported shares. Bpifrance Participations is a subsidiary owned at 99.99% by Bpifrance S.A. ("Bpifrance"). Bpifrance is jointly owned by Caisse des Depots et Consignations ("CDC") at 49.2% and EPIC Bpifrance ("EPIC") at 49.2%. CDC and EPIC jointly control Bpifrance.
F2	Innobio FPCI ("Innobio") directly owns the reported shares. Innobio is a fund managed by Bpifrance Investissement S.A.S. ("Bpifrance Investissement"), a subsidiary owned at 100% by Bpifrance Participations. Bpifrance Investissement may be deemed the beneficial owner of the reported shares, through its management of Innobio.
F3	The exercise of one warrant will give the right to subscribe to 1.75 ordinary shares at a price of (euro)1.5939 per warrant.